A2A receptor antagonist 4-(2-((6-Amino-9-ethyl-8-(furan-2-yl)-9H-purin-2-yl)amino)ethyl)phenol, a promising adenosine derivative for glioblastoma treatment
2025 · European Journal of Pharmaceutical Sciences · 4 citations
https://doi.org/10.1016/j.ejps.2025.107039